Xylem (XYL)
(Delayed Data from NYSE)
$132.40 USD
+1.79 (1.37%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $132.41 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for Xylem Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,019 | 944 | 1,349 | 1,875 | 724 |
Receivables | 1,617 | 1,096 | 953 | 923 | 1,036 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,018 | 799 | 700 | 558 | 539 |
Other Current Assets | 230 | 173 | 158 | 167 | 151 |
Total Current Assets | 3,884 | 3,012 | 3,160 | 3,523 | 2,450 |
Net Property & Equipment | 1,169 | 630 | 644 | 657 | 658 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 10,116 | 3,649 | 3,808 | 3,947 | 4,013 |
Deposits & Other Assets | 943 | 661 | 664 | 623 | 589 |
Total Assets | 16,112 | 7,952 | 8,276 | 8,750 | 7,710 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 968 | 723 | 639 | 569 | 597 |
Current Portion Long-Term Debt | 16 | 0 | 0 | 600 | 276 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,221 | 867 | 752 | 787 | 628 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2,205 | 1,590 | 1,391 | 1,956 | 1,501 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 557 | 222 | 287 | 242 | 310 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,268 | 1,880 | 2,440 | 2,484 | 2,040 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 906 | 757 | 932 | 1,092 | 892 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5,936 | 4,449 | 5,050 | 5,774 | 4,743 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 2 | 2 | 2 | 2 |
Capital Surplus | 8,564 | 2,134 | 2,089 | 2,037 | 1,991 |
Retained Earnings | 2,601 | 2,292 | 2,154 | 1,930 | 1,866 |
Other Equity | -259 | -217 | -363 | -405 | -365 |
Treasury Stock | 733 | 708 | 656 | 588 | 527 |
Total Shareholder's Equity | 10,176 | 3,503 | 3,226 | 2,976 | 2,967 |
Total Liabilities & Shareholder's Equity | 16,112 | 7,952 | 8,276 | 8,750 | 7,710 |
Total Common Equity | 10,176 | 3,503 | 3,226 | 2,976 | 2,967 |
Shares Outstanding | 241.00 | 180.20 | 180.30 | 180.20 | 180.00 |
Book Value Per Share | 42.22 | 19.44 | 17.89 | 16.51 | 16.48 |
Fiscal Year End for Xylem Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 1,019 | 705 | 708 | 837 |
Receivables | NA | 1,617 | 1,653 | 1,659 | 1,123 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1,018 | 1,080 | 1,143 | 857 |
Other Current Assets | NA | 230 | 213 | 225 | 193 |
Total Current Assets | NA | 3,884 | 3,651 | 3,735 | 3,010 |
Net Property & Equipment | NA | 1,169 | 1,132 | 1,144 | 631 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 10,116 | 10,188 | 10,296 | 3,653 |
Deposits & Other Assets | NA | 943 | 934 | 922 | 646 |
Total Assets | NA | 16,112 | 15,905 | 16,097 | 7,940 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 968 | 943 | 968 | 710 |
Current Portion Long-Term Debt | NA | 16 | 17 | 240 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 1,221 | 1,160 | 1,074 | 784 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 2,205 | 2,120 | 2,282 | 1,494 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 557 | 724 | 738 | 215 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2,268 | 2,253 | 2,267 | 1,881 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 867 | 900 | 761 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 5,936 | 5,964 | 6,187 | 4,351 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 3 | 3 | 3 | 2 |
Capital Surplus | NA | 8,564 | 8,529 | 8,495 | 2,152 |
Retained Earnings | NA | 2,601 | 2,416 | 2,344 | 2,331 |
Other Equity | NA | -259 | -289 | -215 | -180 |
Treasury Stock | NA | 733 | 718 | 717 | 716 |
Total Shareholder's Equity | NA | 10,176 | 9,941 | 9,910 | 3,589 |
Total Liabilities & Shareholder's Equity | NA | 16,112 | 15,905 | 16,097 | 7,940 |
Total Common Equity | 0 | 10,176 | 9,941 | 9,910 | 3,589 |
Shares Outstanding | 242.40 | 241.00 | 241.00 | 240.80 | 180.60 |
Book Value Per Share | 0.00 | 42.22 | 41.25 | 41.15 | 19.87 |